Not sure if it really matters what he said. Nobody wants high dose chemo anymore and RC110 has been knocked on the head.
Dom got a promo while taking the FTO data so although his name is connected to the abstract don't expect anything special from him.
Cardio protect is our only hope. Maybe there was half a dozen riveted science groupies listening in that might Twitter a report that we can all drool over.
We need ArsC220 in patients in low doses. Until then expect the unexpected. Hehe
General Comments / Chat, page-9769
-
- There are more pages in this discussion • 2,382 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 38353 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |